Drug price fixing allegation may be increasingly problematic for makers: Analyst

David Maris, research analyst at Wells Fargo, joins CNBC's "Power Lunch" team to discuss how big drug makers are trading amid allegations of price fixing.

Power Lunch,CNBC,business news,finance stock,stock market,news channel,news station,breaking news,us news,world news,cable,cable news,finance news,money,money tips,financial news,stock market news,stocks,